Aurobindo Pharma arm’s biosimilar gets Health Canada NOC
Published on: Jan. 9, 2026, 11:01 p.m. | Source: The Hindu
Aurobindo Pharma's subsidiary receives Health Canada NOC for Dyrupeg, confirming its pegylated filgrastim biosimilar's safety and efficacy.
